Posts published in “Psilocybin”

The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation

BACKGROUND: Psilocybin, a psychoactive serotonin receptor partial agonist, has been reported to acutely reduce clinical symptoms of depressive disorders. Psilocybin’s effects on cognitive function have…

Functional neuroimaging correlates of finger-tapping task variations: an ALE meta-analysis

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin

Cortical activations during paces finger-tapping applying visual and auditory pacing stimuli

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Pharmacologic Similarities and Differences Among Hallucinogens

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

Psilocybin: From Serendipity to Credibility?

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity

The pharmacology of psilocybin

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

The Therapeutic Potential of Psilocybin

The therapeutic potential of microdosing psychedelics in depression

Psychedelic science in post-COVID-19 psychiatry

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Psychedelic perceptions: mental health service user attitudes to psilocybin therapy

Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex

Toxicology and Analysis of Psychoactive Tryptamines

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

Spontaneous and deliberate creative cognition during and after psilocybin exposure

Dose-response relationships of psilocybin-induced subjective experiences in humans